๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma

โœ Scribed by S.D. Heys; o. Eremin; E.M. Ruggeri; F. Pein; H. Rainer; R. Oskam; R.A. de Peuter; P.A. Palmer; C.R. Franks


Book ID
116166094
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
854 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A comprehensive review of 5-fluorouracil
โœ David Machover ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 2 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity